Comparison of the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio Alone versus a Multi-Marker Regression Model for the Prediction of Preeclampsia-Related Adverse Outcomes after 34 Weeks of Gestation.

Sroka, Dorota; Lorenz-Meyer, Lisa-Antonia; Scherfeld, Valerie; Thoma, Julie; Busjahn, Andreas; Henrich, Wolfgang; Verlohren, Stefan

Sroka, Dorota; Lorenz-Meyer, Lisa-Antonia; Scherfeld, Valerie; Thoma, Julie; Busjahn, Andreas; Henrich, Wolfgang; Verlohren, Stefan.

Afiliação

Sroka D; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany, dorota.sroka@charite.de.
Lorenz-Meyer LA; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Scherfeld V; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thoma J; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Busjahn A; HealthTwist GmbH, Berlin, Germany.
Henrich W; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Verlohren S; Department of Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Fetal Diagn Ther ; 50(3): 215-224, 2023.

Article em En | MEDLINE | ID: mdl-36809755

Assuntos

Pré-Eclâmpsia; Feminino; Humanos; Gravidez; Biomarcadores; Fator de Crescimento Placentário; Pré-Eclâmpsia/diagnóstico; Valor Preditivo dos Testes; Estudos Retrospectivos; Receptor 1 de Fatores de Crescimento do Endotélio Vascular

Palavras-chave

Adverse outcome; Late-onset preeclampsia; Prediction; Preeclampsia; Soluble fms-like tyrosine kinase 1/placental growth factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google